Cas:50270-33-2 2-(2,4,5-triphenylpyrazol-3-yl)acetic acid manufacturer & supplier

Chemical Name:2-(2,4,5-triphenylpyrazol-3-yl)acetic acid

CAS.NO:50270-33-2

Synonyms:Isofezolacum [INN-Latin];Isofezolacum;Isofezolaco [INN-Spanish];(2,4,5-triphenyl-2H-pyrazol-3-yl)-acetic acid;1,3,4-triphenyl-1h-pyrazole-5-acetic acid;1,3,4-Triphenyl-5-pyrazolessigsaeure;Isofezolaco;1,3,4-triphenyl-5-pyrazolylacetic acid;Isofezolac

Molecular Formula:C₂₃H₁₈N₂O₂

Molecular Weight:354.40100

HS Code:2933199090

Physical and Chemical Properties:

Melting point:N/A

Boiling point:542.8ºC at 760 mmHg

Density:1.18g/cm3

Index of Refraction:1.635

PSA:55.12000

Exact Mass:354.13700

LogP:4.83340

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Isofezolacum [INN-Latin] chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Isofezolac physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Isofezolac Use and application,Isofezolaco [INN-Spanish] technical grade,usp/ep/jp grade.

Related News: Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. 2-(2,4,5-triphenylpyrazol-3-yl)acetic acid manufacturer Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. 2-(2,4,5-triphenylpyrazol-3-yl)acetic acid supplier Over the past twelve months, the collaboration team has worked to optimize its processes for making T cells from iPSCs, and has now shown the production of pure T-lymphocytes consisting of both CD8+ and CD4+ T cells having a global gene expression profile that is highly-similar to primary T cells based on a principal component analysis. 2-(2,4,5-triphenylpyrazol-3-yl)acetic acid vendor At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. 2-(2,4,5-triphenylpyrazol-3-yl)acetic acid factory While they are early data, “it’s also very reassuring that those patients who have progressed can be rather easily reinduced into remission,” Tendler said. J&J and AbbVie are now taking the same approach for the GLOW study, he added.